Open Access

Texture analysis of early cerebral tissue damage in magnetic resonance imaging of patients with lung cancer

  • Authors:
    • Jiying Xu
    • Xiaoxiao Cui
    • Bomin Wang
    • Guangyu Wang
    • Meng Han
    • Ranran Li
    • Yana Qi
    • Jianjun Xiu
    • Qianlong Yang
    • Zhi Liu
    • Mingyong Han
  • View Affiliations

  • Published online on: March 3, 2020     https://doi.org/10.3892/ol.2020.11426
  • Pages: 3089-3100
  • Copyright: © Xu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Primary tumors can secrete many cytokines, inducing tissue damage or microstructural changes in distant organs. The purpose of this study was to investigate changes in texture features in the cerebral tissue of patients with lung cancer without brain metastasis. In this study, 50 patients with lung cancers underwent 3.0‑T magnetic resonance imaging (MRI) within 2 weeks of being diagnosed with lung cancer. Texture analysis (TA) was carried out in 8 gray matter areas, including bilateral frontal cortices, parietal cortices, occipital cortices and temporal cortices, as well as 2 areas of bilateral frontoparietal white matter. The same procedure was performed for 57 healthy controls. A total of 32 texture parameters were separately compared between the patients and controls in the different cerebral tissue sites. Texture features among patients based on histological type and clinical stage were also compared. Of the 32 texture parameters, 27 showed significant differences between patients with lung cancer and healthy controls. There were significant differences in cerebral tissue, both gray matter and white matter between patients and controls, especially in several wavelet‑based parameters. However, there were no significant differences between tissue at homologous sites in bilateral hemispheres, either in patients or controls. TA detected overt changes in the texture features of cerebral tissue in patients with lung cancer without brain metastasis compared with those of healthy controls. TA may be considered as a novel and adjunctive approach to conventional brain MRI to reveal cerebral tissue changes invisible on MRI alone in patients with lung cancer.

Introduction

According to the 2018 Global Cancer Statistics, lung cancer is the leading cause of cancer-associated mortality worldwide (1) and was so in China in 2014 (2). However, the cure for lung cancer remains elusive due to the aggressive and disseminative nature of tumors which restricts the efficacy of cancer treatments (3). The brain is a preferential site of metastasis in lung cancer (4). Among patients with lung cancer, ~30–50% develop brain metastasis (57), which substantially affects their quality of life. However, in the present study, even in the absence of brain metastasis, some individuals continued to exhibit paraneoplastic neurological syndromes, such as behavioral, memory and movement disorders as well as hypomnesis, dizziness and headaches (8). A number of previous studies have hypothesized that the pathophysiology underlying paraneoplastic syndromes is associated with the secretion of cytokines by the primary tumor (912). This may induce injury to distant organs and cause microstructural changes like those in the brain, which cause paraneoplastic syndromes or alter the homing and proliferation of metastatic cancer cells (913). However, the underlying mechanisms remain unclear.

Due to the potential ability to assess the characteristics of brain tissue noninvasively, magnetic resonance imaging (MRI) is currently the main method used for diagnosis, treatment guidance and monitoring of brain metastasis (14,15). However, identifying early changes in the cerebral tissue of patients with lung cancer without brain metastasis is difficult (16). Fortunately, MRI images of cerebral tissues contain a wealth of information invisible to the human eye that can accessed by texture analysis (TA) techniques (17). Texture is a visual stimulus generated by repetitive image patterns, which can be depicted as regular or irregular, smooth or rough and fine or coarse. Although they can exhibit very complex patterns, some textures can be extracted relatively easily even by visual assessment due to the regular visual appearance of the patterns. However, most textures display random patterns because textural primitives are random, making them difficult to recognize and interpret. In medical images, these types of random textures are more common than regular patterns. As texture is an image feature defined by both pixel locations and brightness value, TA enables mathematical calculation of the patterns. Therefore, texture features provide the potential to distinguish and characterize properties of cerebral tissue (17).

The aim of the present study was to use texture analysis (TA) methods to describe early cerebral tissue damage caused by lung cancer without brain metastasis.

Materials and methods

Subjects

The present study was approved by the Ethics Committee of Shandong Provincial Hospital Affiliated to Shandong University (Jinan, China). Written informed consent was obtained from all patients prior to the study start. Patients with lung cancer were recruited from the Shandong Provincial Hospital between December 2017 and October 2018. The TA study included 50 consecutive patients (36 males, 14 females; mean age, 60 years; age range 47–75 years) who were all diagnosed by pathology and met the diagnostic criteria for primary lung cancer according to the World Health Organization (18). In addition to a detailed review of pathological specimens by pathologists upon admission to the hospital, all patients with lung cancer underwent a careful physical examination performed by experienced oncologists and neurologists from Shandong Provincial Hospital Affiliated to Shandong University, in order to determine the clinical stage, Karnofsky Performance Scale (KPS) score (19) and numeric rating scale score (NRS) (20). The demographic information and clinical characteristics of the patients are presented in Table I. The inclusion criteria were as follows: i) Age, 18–75 years; ii) histological type of small cell carcinoma, squamous cell carcinoma, adenocarcinoma and others; iii) KPS score >60 and iv) no neurological abnormalities. The exclusion criteria were as follows: i) Age, <18 years or >75 years; ii) systemic illness such as systemic lupus erythematosus, serious vascular disease, head trauma, epilepsy (healthy controls) or claustrophobia; iii) long-term use of psychoactive medication and iv) refusal to undergo MRI. The control group (CG) comprised of 57 age- and sex-matched healthy volunteers. The individuals in this group reported no types of malignant tumor or any systemic, neurological or psychiatric illnesses known to affect cerebral structure or function such as a long history of psychoactive medication use, head trauma, serious vascular disease, current depression, epilepsy or alcoholism.

Table I.

Clinical characteristics of the studied groups.

Table I.

Clinical characteristics of the studied groups.

CharacteristicsPatient, n=50Control, n=57
Age in years, mean ± standard deviation60.0 ± 7.259.1 ± 6.5
Age range, years47–7548–75
Gender, Female vs. Male36/1437/20
Histological type, n
  Adenocarcinoma29
  Squamous17
  Small cell4
Clinical stage
  Early18
  Advanced32
Karnofsky performance scale
  ≥7049
  <701
Numeric rating scales
  ≤337
  >313
MRI examinations

Data were acquired within 2 weeks of diagnosis of lung cancer primarily due to some patients being diagnosed in other hospitals and then transferred to Shandong Provincial Hospital for further antitumor treatment. Following diagnosis, all patients underwent conventional MRI using a 3.0-T scanner (Philips Medical Systems B.V.) equipped with an 8-channel head and neck coil. The MRI machine was included in a detailed quality control plan requiring daily, monthly and quarterly inspections. The radio frequency amplifier properties and main magnetic field homogeneity of the MRI machine were measured and controlled quarterly. The following conventional MRI sequences were employed: Sagittal, coronal and axial T2-weighted imaging (T2WI), T1-weighted imaging (T1WI), fluid-attenuated inversion recovery imaging, diffusion-weighted imaging, apparent diffusion coefficient and enhanced T1WI. The sequences employed in the MRI protocol are presented in Table II.

Table II.

MRI sequences included in the magnetic resonance protocol of the present study.

Table II.

MRI sequences included in the magnetic resonance protocol of the present study.

SequenceTRTETISlice/gapMatrixFOVFlip angle
Axial T2WI4,00010006.0/1.0384×38423090
Axial TIWI–IR3,000  431,1506.0/1.0264×264230
Axial FLAIR9,0001482,5006.0/1.0284×284230
DWI2,257  7106.0/1.0152×15223090
Axial T1W-STIR3,000  431,1506.0/1.0264×264230

[i] TR, repetition time; TE, echo time; TI, inversion time; FOV, field of view; T1WI, T1-weighted imaging; T2WI, T2-weighted imaging; DWI, diffusion-weighted imaging; FLAIR, fluid-attenuated inversion recovery; IR, inverse recovery; STIR, short time inversion recovery.

MR image segmentation

Image selection was carried out using a DICOM viewer (version 3.0; Philips Medical Systems B.V.). For each MR image, regions of interest (ROIs) were drawn symmetrically by hand on bilateral sides of the hemispheres at each level of interest (21,22). In the present study, 16×16-pixel ROIs were manually drawn on the frontoparietal white matter in the centrum semiovale (Fig. 1A), frontal cortices and parietal cortices at the level of the body of the lateral ventricles (Fig. 1B), occipital cortices at the level of the basal ganglia (Fig. 1C) and temporal cortices at the level of the midbrain (Fig. 1D). The ROIs were carefully placed by two experienced neuroradiologists from Shandong Provincial Hospital Affiliated to Shandong University, to avoid overlap with any areas of microhemorrhage, hyperintensity or macroscopic hemosiderin depositions which may occur in some patients. Fig. 2 presents an array of texture blocks extracted from the cerebral tissues of a patient with lung cancer, without metastasis and a healthy volunteer.

TA analysis technique

The axial T2WI sequence was selected from the whole MRI study for TA as T2-weighted MR imaging has been demonstrated to be sensitive to tissue abnormalities in the human brain (23). Only single slices were evaluated to obtain a maximum in-plane resolution by avoiding the lower resolution or interpolation, typically caused by 3-dimensional TA (24). Further analysis was performed using 4 MRI image slices selected from the T2WI sequence at 4 interest levels. The texture features in 10 ROIs were assessed based on the histogram, gray-level co-occurrence matrix (GLCM), gray-level run length matrix (GLRLM) and wavelet transform, as summarized in Table III (17,25,26). The wavelet transform of the three dimensional image was the decomposition of the image along the x, y and z directions using low-pass filter (L) and high-pass filter (H), and each layer of wavelet decomposition decomposed the image data into eight different frequency bands (LLH, HLL, HLH, HHL, LHL, LHH, HHH and LLL), which included seven high frequency bands (LLH-HHH) and one low frequency band (LLL).

Table III.

List of texture features.

Table III.

List of texture features.

HistogramGray-level co-occurrence matrixGray-level run length matrixWavelet
MeanJoint energyLong run emphasisHHH_kurtosis
SkewnessInverse differenceRun length non-uniformityHHL_maximum
DeviationCorrelationLow gray-level run emphasisHLH_skewness
VarianceDifference averageShort run low gray-level emphasisLLL_10 percentile
KurtosisDifference entropyLong run low gray-level emphasisLLL_median
Inverse difference normalizedShort run high gray-level emphasisLLL_minimum
Joint entropyLong run high gray-level emphasisLLL_variance
Sum averageShort run emphasis
Sum entropyRun gray-level non-uniformity
Run percentage
High gray-level run emphasis

[i] LLL, low frequency-low frequency-low frequency output; HHH, high frequency-high frequency-high frequency output; HHL, high frequency- high frequency-low frequency output; HLH, high frequency-low frequency-high frequency output.

The first order statistics image properties derived from the gray-scale frequency histogram depend solely on individual pixel values. Second order statistics are properties of pixel pairs and describe the relationship between pixels and their grey levels. However, the first and second order statistics of images in texture analysis only contained the amplitude information of the image, ignoring the phase information, thus the wavelet transform of the image was also analyzed. TA was performed using the Python language (version 3.6) on the JetBrains PyCharm platform (version 2018.1.3). Feature calculations were performed within the Pyradiomics package (version 2.2.0), which is an open-source Python package designed for the extraction of radiomic features from medical images (27). As the Fisher criterion can produce an array of features with highly discriminative power, a feature selection method was applied using the Fisher coefficient provided by the Python package, in order to identify the six texture features with the highest discriminatory potential for classification (17).

Statistical analysis

In total, 32 texture parameters were tested to determine which and how many features in each ROI demonstrated significant differences between patients with lung cancer, without brain metastasis and healthy controls. Statistical analyses were performed for each texture feature. Differences in texture features between the two groups were analyzed via the Wilcoxon rank sum test or Mann-Whitney U test, using SPSS software (version 22; IBM Corp.). The Fisher coefficient was used to select the six most discriminative parameters. P<0.05 was considered to indicate a statistically significant difference.

Results

Analysis workflow

Given brain MRI data sets of patients with lung cancer without brain metastasis and healthy controls, four interest levels were selected, and then texture blocks of 16×16 pixels were manually placed in a symmetrical manner on bilateral sides of the hemispheres at each level of interest. Finally, texture features were calculated based on the image histogram, the co-occurrence matrix, the run-length matrix and wavelets. The system diagram presented in Fig. 3 represents the process followed for MRI analysis.

Brain MRI of patients with lung cancer and healthy controls

In this study, conventional MRI enabled detection of lesions related to brain metastasis or primary brain tumors only when gross structural abnormalities could be visually detected. Based on the conventional MR images, no significantly different signals were found in any sequence in patients with lung cancer without metastasis compared with healthy volunteers (Table II). Fig. 4 shows conventional MR images of a 45-year-old female patient who presented with lung cancer without brain metastasis (top row) and a 54-year-old male healthy control (bottom row).

Comparison of texture parameters in bilateral hemispheres between patients with lung cancer without brain metastasis and healthy controls

For the comparison of bilateral hemispheres of 10 ROIs, 32 features were tested for each texture block to determine which and how many of the parameters differed statistically between patients with primary lung cancer without brain metastasis and healthy controls. The number of texture parameters (n=32) which were significantly different were analyzed using the Wilcoxon test (Table IV). The feature vector included mean and variance features from histogram statistics, energy and correlation features from a co-occurrence matrix, short-run and long-run emphasis features from a run-length matrix and phase information features from wavelet transform. The 32 texture parameters included; Five histogram-based parameters, nine GLCM-based parameters, 11 GLRLM-based parameters and seven wavelet-based parameters. Among the five histogram-based parameters, which depended solely on individual pixel gray-level values, the following four parameters; mean, skewness, deviation and variance were significantly different (P<0.05), and only the kurtosis parameter demonstrated no significant difference (P=0.686). Among the nine GLCM-based parameters, seven parameters were significantly different; however, the parameters for correlation (P=0.435) and normalized inverse difference (P=0.156) demonstrated no significant differences. All 11 GLRLM-based parameters were significantly different (P<0.05). Among the seven wavelet-based parameters, five parameters were significantly different (P<0.05), whereas wavelet-HHH_kurtosis and wavelet-HLH_skewness failed to demonstrate statistically significant differences (P>0.05, respectively) (Table IV). There were 27 texture parameters with a statistically significant difference including 4 histogram-based parameters, 7 GLCM-based parameters, 11 GLRLM-based parameters and 5 wavelet-based parameters. The feature parameters with statistically significant differences were in first order features, second order features and wavelets. For instance, mean indicated the average density among the texture blocks; deviation calculated the statistical variability of density among the pixels in the blocks; sum average indicated the total number of correlated pixel pairs with the same sum in the block; gray-level non-uniformity referred to the orderliness or randomness of the pixel densities among the blocks which could denote the degree of structure, and gray-level run length emphasis measured consecutive pixels of the same density along particular orientations as another representation of structure.

Table IV.

Comparison of texture features between patients with lung cancer and healthy controls.

Table IV.

Comparison of texture features between patients with lung cancer and healthy controls.

FeaturePatient, mean (SD)Control, mean (SD)P-value
Kurtosis3.649 (1.88)3.707 (2.57)0.686
Mean544.176 (167.18)688.647 (209.26)<0.001
Skewness0.614 (0.61)0.465 (0.67)0.001
Deviation64.877 (42.55)78.146 (47.07)<0.001
Variance6,016.221 (460.30)8,319.324 (434.89)<0.001
Correlation0.806 (0.14)0.800 (0.15)0.435
Difference average0.873 (0.43)1.063 (0.51)<0.001
Difference entropy1.584 (0.41)1.749 (0.45)<0.001
Inverse difference0.674 (0.09)0.631 (0.09)<0.001
Inverse difference normalized0.941 (0.01)0.939 (0.01)0.156
Joint energy0.073 (0.06)0.057 (0.06)<0.001
Joint entropy4.772 (1.16)5.193 (1.22)<0.001
Sum average11.151 (5.34)14.097 (8.38)<0.001
Sum entropy3.791 (0.85)4.044 (0.90)<0.001
Gray-level non-uniformity22.665 (9.16)21.697 (10.55)<0.001
High gray-level run emphasis52.799 (65.99)86.091 (127.81)<0.001
Long run emphasis4.592 (2.71)3.605 (1.98)<0.001
Long run high gray-level emphasis135.634 (99.71)195.944 (295.67)<0.001
Long run low gray-level emphasis0.640 (0.94)0.403 (0.59)<0.001
Low gray-level run emphasis0.108 (0.08)0.086 (0.07)<0.001
Run length non-uniformity80.196 (33.18)96.709 (34.77)<0.001
Run percentage0.618 (0.11)0.673 (0.10)<0.001
Short run emphasis0.694 (0.10)0.741 (0.09)<0.001
Short run high gray-level emphasis43.297 (60.87)71.963 (107.37)<0.001
Short run low gray-level emphasis0.067 (0.04)0.058 (0.04)<0.001
wavelet-HHH_kurtosis8.636 (7.28)8.702 (7.19)0.932
wavelet-HHL_maximum35.940 (30.20)45.996 (40.29)<0.001
wavelet-HLH_skewness−0.224 (1.21)−0.263 (1.34)0.930
wavelet-LLL_10 percentile1,358.451 (402.93)1,689.975 (524.57)<0.001
wavelet-LLL_median1,544.083 (19.83)1,927.296 (585.72)<0.001
wavelet-LLL_minimum1,257.445 (375.73)1,538.135 (509.09)<0.001
wavelet-LLL_variance46,637.723 (84568.84)64,229.389 (80765.98)<0.001

[i] A total of 32 texture parameters were evaluated. The parameters that demonstrated statistically significant differences between patients with lung cancer and health controls are presented in bold. P<0.05 was considered to indicate a statistically significant difference. LLL, low frequency-low frequency-low frequency output; HHH, high frequency-high frequency-high frequency output; HHL, high frequency-high frequency-low frequency output; HLH, high frequency-low frequency-high frequency output.

Identification of the six most discriminative parameters between patients with lung cancer without brain metastasis and healthy controls

When the texture parameters of 10 ROIs were compared in bilateral hemispheres between the lung cancer group and the healthy control group, 27 of the 32 were significantly different. Among the 27 significantly different parameters, six texture features were identified using the Fisher coefficient provided by the Python package. The Fisher criterion could produce a set of features with a high discriminatory potential for separation and classification which were also highly associated with each other. Based on the Fisher coefficient and the values obtained by the Wilcoxon test, the six most discriminative parameters for differences between patients and healthy controls were selected. These six texture parameters were the wavelet-LLL_median, mean, wavelet-LLL_ 10 percentile, wavelet-LLL_ minimum, run percentage, and run length non-uniformity. The six most discriminative texture features were extracted from the first-order statistics, second-order statistics and wavelets. However, the six texture features were mainly based on the wavelets and GLRLM features (Fig. 5).

Comparison of the top six texture parameters between the left and right hemispheres in patients with lung cancer without brain metastasis and healthy controls

The comparison of bilateral hemispheres of patients with lung cancer and healthy controls, proved that TA had a high discriminatory potential, but its stability needed to be further confirmed. Firstly, the difference between bilateral hemispheres in the controls was compared using the six most discriminative parameters (Table V). For these six texture parameters, there were no significant differences between the bilateral hemispheres based on the Wilcoxon test. Subsequently, the six most discriminative parameters were used to find out if primary lung cancer had the same impact on the bilateral hemispheres. For these six texture parameters, there were no significant differences between the bilateral hemispheres in patients with lung cancer (Table V).

Table V.

Comparison of the top six texture features between the left and right hemispheres in patients with lung cancer, without brain metastasis and healthy controls.

Table V.

Comparison of the top six texture features between the left and right hemispheres in patients with lung cancer, without brain metastasis and healthy controls.

FeaturePatients Right, mean (SD)Left, mean (SD)P-valueControls Right, mean (SD)Left, mean (SD)P-value
LLL_median1,526.338 (442.99)1,561.828 (478.29)0.4921,906.664 (580.25)1,947.927 (591.44)0.364
Mean548.260 (160.31)560.092 (173.88)0.554681.227 (206.92)696.062 (211.67)0.375
LLL_10 percentile1,344.940 (387.64)1,371.958 (417.95)0.4681,668.751 (520.21)1,711.199 (528.96)0.284
LLL_minimum1,246.636 (365.12)1,268.253 (386.43)0.5281,536.064 (488.56)1,540.206 (529.67)0.590
Run percentage0.616 (0.11)0.621 (0.11)0.6650.672 (0.10)0.673 (0.10)0.890
Run length non-uniformity19.620 (32.86)80.760 (33.54)0.69296.930 (35.30)96.470 (34.29)0.875

[i] P<0.05 was considered to indicate a statistically significant difference. LLL, low frequency-low frequency-low frequency output; HHH, high frequency-high frequency-high frequency output; HHL, high frequency-high frequency-low frequency output; HLH, high frequency-low frequency-high frequency output.

Comparison of the top six texture parameters between gray and white matter in patients with lung cancer without brain metastasis and healthy controls

The top six texture parameters were tested to find out how many and which of them differed statistically between gray and white matter. The texture features of gray and white matter in patients with lung cancer and healthy controls were also analyzed using the Wilcoxon test and based on the top six texture parameters. An identical trend between gray and white matter was observed in the patient and control groups. Among the six parameters, four parameters were significantly different between the patient and control groups. These four parameters were wavelet-LLL_median, wavelet-LLL_ 10 percentile, wavelet-LLL_ minimum, and run length non-uniformity. The parameters of mean and run percentage showed no significant difference (Table VI).

Table VI.

Comparison of the top six texture features between gray matter and white matter in patients with lung cancer, without brain metastasis and healthy controls.

Table VI.

Comparison of the top six texture features between gray matter and white matter in patients with lung cancer, without brain metastasis and healthy controls.

PatientsControls


FeatureGray matter, mean (SD)White matter, mean (SD)P-valueGray matter, mean (SD)White matter, mean (SD)P-value
LLL_median1,578.194 (470.68)1,407.642 (392.67)0.0011,974.210 (599.28)1,739.639 (486.80)<0.001
Mean567.995 (170.78)498.900 (139.48)<0.001706.957 (213.88)615.395 (171.85)<0.001
LLL_10 percentile1,362.905 (410.33)1,340.638 (373.17)0.6081,694.792 (538.49)1,670.707 (466.43)0.661
LLL_minimum1,250.471 (379.24)1,285.339 (361.70)0.3891,521.724 (522.89)1,603.779 (445.74)0.124
Run percentage0.647 (0.09)0.504 (0.09)<0.0010.703 (0.08)0.549 (0.09)<0.001
Run length non-uniformity88.046 (30.90)48.790 (21.37)<0.001106.039 (30.97)59.380 (21.65)<0.001

[i] P<0.05 was considered to indicate a statistically significant difference. LLL, low frequency-low frequency-low frequency output; HHH, high frequency-high frequency-high frequency output; HHL, high frequency-high frequency-low frequency output; HLH, high frequency-low frequency-high frequency output.

Comparison of texture parameters between patients with lung cancer without brain metastasis and healthy controls in cerebral gray and white matter

The aforementioned six most discriminative parameters were used to determine which differed statistically between patients with lung cancer without brain metastasis and healthy controls in different cerebral regions. In white matter regions, all six texture parameters analyzed with Wilcoxon test showed significant differences between patients and controls (Table VII). The six most discriminative parameters were subsequently tested to determine whether primary lung cancer has the same effect on the gray matter regions. For these six texture parameters, all showed significant differences between patients and controls (Table VII).

Table VII.

Comparison of the top six texture features between cerebral gray and white matter in patients with lung cancer, without brain metastasis and healthy controls.

Table VII.

Comparison of the top six texture features between cerebral gray and white matter in patients with lung cancer, without brain metastasis and healthy controls.

Gray matterWhite matter


FeaturePatients, mean (SD)Controls, mean (SD)P-valuePatients, mean (SD)Controls, mean (SD)P-value
LLL_median1,578.194 (470.68)1,974.210 (599.28)<0.0011,407.642 (392.67)1,739.639 (486.80)<0.001
Mean567.995 (170.78)706.957 (213.88)<0.001498.900 (139.48)615.395 (171.85)<0.001
LLL_10 percentile1,362.905 (410.33)1,694.792 (538.49)<0.0011,340.638 (373.17)1,670.707 (466.43)<0.001
LLL_minimum1,250.471 (379.24)1,521.724 (522.89)<0.0011,285.339 (361.70)1,603.779 (445.74)<0.001
Run percentage0.647 (0.09)0.703 (0.08)<0.0010.504 (0.09)0.549 (0.09)<0.001
Run length non-uniformity88.046 (30.90)106.039 (30.97)<0.00148.790 (21.37)59.380 (21.65)<0.001

[i] P<0.05 was considered to indicate a statistically significant difference. LLL, low frequency-low frequency-low frequency output.

Comparison of the texture features by clinical stage in patients with lung cancer without brain metastasis

To investigate the relationship between the texture parameters of brain MR images and clinical lung cancer stages, which was a revised 2017 edition of the American Joint Committee on Cancer (AJCC) Cancer Staging Manual (28,29), patients with lung cancer, without brain metastasis were divided into two groups: Stage I+II and stage III+IV. The top six texture parameters were tested to find out how many and which of them differed statistically between the 2 patient groups. All of the six texture parameters were significantly different between the patient groups (Table VIII). Compared to the stage I+II group, all six parameters were significantly greater in the stage III+IV group (Table VIII).

Table VIII.

Comparison of the top six texture features between different clinical stages in patients with lung cancer, without brain metastasis.

Table VIII.

Comparison of the top six texture features between different clinical stages in patients with lung cancer, without brain metastasis.

FeatureStage I+II, mean (SD)Stage III+IV, mean (SD)P-value
LLL_median1,348.190 (196.51)1,649.503 (525.46)<0.001
Mean482.068.995 (72.08)592.987 (190.12)<0.001
LLL_10 percentile1,181.089 (183.65)1,453.300 (455.26)<0.001
LLL_minimum1,093.485 (171.46)1,344.760 (425.07)<0.001
Run percentage0.580 (0.10)0.636 (0.11)<0.001
Run length non-uniformity70.024 (27.21)85.705 (34.94)<0.001

[i] P<0.05 was considered to indicate a statistically significant difference. LLL, low frequency-low frequency-low frequency output.

Comparison of the top six texture features by histological type

The main histological types of lung cancer are squamous cell carcinoma, adenocarcinoma and small cell lung cancer (SCLC). The top six texture parameters were compared among these groups to establish associations between the brain MRI texture parameters and the histological types (Table IX). The top six texture parameters showed no significant differences between the squamous cell and adenocarcinoma groups but were all significantly different between the SCLC group compared with the other groups. Compared to the adenocarcinoma group, the SCLC group showed significantly increased texture parameters; similar results were observed between the squamous cell carcinoma and SCLC groups.

Table IX.

Comparison of the top six texture features between different histological types in patients with lung cancer, without brain metastasis.

Table IX.

Comparison of the top six texture features between different histological types in patients with lung cancer, without brain metastasis.

Mean (SD)P-value


FeatureAdSqSmAd vs. SqAd vs. SmSq vs. Sm
LLL_median1,450.823 (18.75)1,544.848 (449.86)2,565.255 (451.93)0.334<0.001<0.001
Mean519.909 (124.32)555.842 (164.23)921.111 (158.10)0.234<0.001<0.001
LLL_10 percentile1,274.496 (300.34)1,362.517 (378.48)2,268.574 (413.46)0.141<0.001<0.001
LLL_minimum1,176.569 (281.63)1,267.834 (350.97)2,084.727 (425.21)0.051<0.001<0.001
Run percentage0.603 (0.11)0.623 (0.09)0.759 (0.06)0.145<0.001<0.001
Run length non-uniformity75.889 (31.78)80.426 (30.69)126.191 (28.12)0.158<0.001<0.001

[i] Ad, adenocarcinoma; Sq, squamous cell; Sm, small cell; LLL, low frequency-low frequency-low frequency output.

Discussion

In light of recent advances in the acquisition and analysis of MR images for the high-throughput extraction of imaging feature information, medical imaging can now be used to quantify the distinguishing features of tumor tissues (3032). This approach is distinct from prior subjective or qualitative methods (14). Applying TA to medical imaging features has been a significant field of research and has generated an extensive body of literature (3335). It has been demonstrated that MR images include tissue-specific texture features that can be extracted by mathematical methods (30). TA can be used to distinguish pathological from healthy human cerebral tissue and to classify different types of cerebral tissue (15,36,37). TA enables the discrimination of multiple sclerosis lesions from normal and normal-appearing white matter (38). However, previous studies have mainly focused on detecting small nodules, that is, the lesions themselves. This study is distinct in that it primarily characterizes early cerebral tissue damage caused by lung cancer before metastasis by applying TA methods. The TA of MRI features can also be used for classifying different cerebral tissues and structures in brain MR images (36,39).

MR images were selected in the current study to detect textural differences in cerebral tissue between patients with primary lung cancer and healthy controls. Of a total of 32 texture parameters tested, 27 parameters were significantly different between patients with lung cancer and healthy controls. The results of this study indicate that in patients with lung cancer, there are differences in the texture parameters of brain MR images of cerebral tissues. It can therefore be inferred that lung cancer can cause early brain tissue damage prior to metastasis.

Among the 27 significantly different parameters, six texture features that best discriminated between patients and healthy controls were identified by calculating Fisher coefficients. These texture parameters were the LLL_median, mean, LLL_percentile, LLL_minimum, run percentage and run length non-uniformity. Using these six parameters, the two cerebral hemispheres and gray and white matter were compared between and within the participant groups. First, the left and right hemispheres of cerebral tissue were compared in the controls, as well as the gray and white matter. It is well known that the human brain is symmetrical in structure and with respect to gray and white matter, there are obvious differences in both composition and function. Gray matter is mainly composed of the cell bodies of neurons, but white matter is principally surrounded by the myelin sheaths of neurons. In regard to functionality, the former contains nerve centers, which play a major role in generating neural activity; the latter, on the other hand, represents the main transmission pathways carrying the neural signals generated by the brain and the gray matter of the spinal cord (40,41). The results of the present study show that the texture parameters were not significantly different between the 2 hemispheres, but 4 of 6 texture parameters were significantly different between gray and white matter. It can therefore be concluded that TA applied to brain MR images is stable and reliable. This analysis was repeated in the patient group and an identical trend was observed, which may indicate that primary lung lesions can cause similar early damage in both hemispheres and that TA can be used to classify different structures. By comparison of different regions of gray and white matter between patients with lung cancer and healthy controls, all six texture parameters were significantly different in both gray matter and white matter. It can be assumed that the overt texture changes are caused by the lung cancer and this leads to similar impairments in both gray and white matter.

Clinical stage is used to describe the severity and range of involvement of malignant tumors according to the original tumor and degree of spread in an individual, which is the basis for understanding the extent of the disease. This information can help doctors develop appropriate treatment plans and understand the prognosis and outcome of the disease. The numerically higher the stage, the more advanced the tumor progression and the worse the prognosis (42). The present study analyzed associations between the clinical stages of lung cancer and texture parameters of MR images. The results revealed that, compared with the early-stage group (stage I+II), the advanced-stage group (stage III+IV) showed a more significant increase in all six parameters. This may indicate that increased parameters are related to more advanced clinical stages of lung cancer.

In addition to the clinical stage, the choice of tumor treatment is also related to the pathological type of the tumor (18,28,4346). Associations with the histological type were also analyzed in this study. The results show that compared to adenocarcinoma group, the SCLC group showed significantly increased texture parameters; similar results were found between the squamous cell carcinoma and SCLC groups. However, the texture parameters assessed in the adenocarcinoma and squamous cell carcinoma groups were not significantly different. It is necessary to note that compared with adenocarcinoma and squamous cell carcinoma, SCLC has a higher degree of malignancy and a worse prognosis (47,48). The significant differences in texture parameters between SCLC and adenocarcinoma or squamous cell carcinoma are possibly attributable to these differences. It can be assumed that greater texture changes are caused by greater degrees of malignancy.

There are several limitations of this study. Firstly, as this is a preliminary experiment, the sample size was relatively small. Furthermore, a limited set of features, rather than a larger set of multiple hundreds or thousands (compound) of features was selected for analysis because the selected texture features have consistently been shown to be effective in the analysis of medical images (25,38,4951) and robust against variations between scanners and protocol parameters (52) especially after normalization (53). Finally, in the absence of confirmation of the early damage to human brain tissue, further pathological investigation using an animal model is required.

In conclusion, this small pilot study indicates that TA with a variable set of texture features can serve as an adjuvant diagnostic tool to traditional MRI to detect early damage in patients with lung cancer without brain metastasis. TA may serve as a new method for the study of tumor metastasis and paraneoplastic syndromes.

Acknowledgements

Not applicable.

Funding

The present study was funded by the National Natural Science Foundation of China (grant no. 81670046).

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Authors' contributions

JX acquired the data, performed the analyses and wrote the initial manuscript. XC and BW performed texture analysis. GW, MH, RL and YQ acquired the data. JX and QY selected ROIs of the MR images. ZL and MH made substantial contributions to the conception and design of the present study. All authors read and approved the final manuscript.

Ethical approval and consent to participate

The present study was approved by the Ethics Committee of Shandong Provincial Hospital Affiliated to Shandong University (Jinan, China). Written informed consent was obtained from all patients prior to the study start.

Patient consent for publication

All patients signed consent for publication.

Competing interests

The authors declare that they have no competing interests.

References

1 

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI

2 

Chen W, Sun K, Zheng R, Zeng H, Zhang S, Xia C, Yang Z, Li H, Zou X and He J: Cancer incidence and mortality in China, 2014. Chin J Cancer Res. 30:1–12. 2018. View Article : Google Scholar : PubMed/NCBI

3 

Masters GA, Temin S, Azzoli CG, Giaccone G, Baker S Jr..Brahmer JR, Ellis PM, Gajra A, Rackear N, Schiller JH, et al: Systemic therapy for stage iv non-small-cell lung cancer: American Society of clinical oncology clinical practice guideline update. J Clin Oncol. 33:3488–3515. 2015. View Article : Google Scholar : PubMed/NCBI

4 

Sul J and Posner JB: Brain metastases: Epidemiology and pathophysiology. Cancer Treat Res. 136:1–21. 2007. View Article : Google Scholar : PubMed/NCBI

5 

Langley RR and Fidler IJ: The seed and soil hypothesis revisited-the role of tumor-stroma interactions in metastasis to different organs. Int J Cancer. 128:2527–2535. 2011. View Article : Google Scholar : PubMed/NCBI

6 

Landis SH, Murray T, Bolden S and Wingo PA: Cancer statistics, 1998. CA Cancer J Clin. 48:6–29. 1998. View Article : Google Scholar : PubMed/NCBI

7 

Sawaya R: Considerations in the diagnosis and management of brain metastases. Oncology. 15:1145–1163. 2001.

8 

Leypoldt F and Wandinger KP: Paraneoplastic neurological syndromes. Clin Exp Immunol. 175:336–348. 2014. View Article : Google Scholar : PubMed/NCBI

9 

Gassmann P, Haier J, Schlüter K, Domikowsky B, Wendel C, Wiesner U, Kubitza R, Engers R, Schneider SW, Homey B and Müller A: CXCR4 regulates the early extravasation of metastatic tumor cells in vivo. Neoplasia. 11:651–661. 2009. View Article : Google Scholar : PubMed/NCBI

10 

Erler JT, Bennewith KL, Cox TR, Lang G, Bird D, Koong A, Le QT and Giaccia AJ: Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell. 15:35–44. 2009. View Article : Google Scholar : PubMed/NCBI

11 

Erler JT and Weaver VM: Three-dimensional context regulation of metastasis. Clin Exp Metastasis. 26:35–49. 2009. View Article : Google Scholar : PubMed/NCBI

12 

Hiratsuka S, Goel S, Kamoun WS, Maru Y, Fukumura D, Duda DG and Jain RK: Endothelial focal adhesion kinase mediates cancer cell homing to discrete regions of the lungs via E-selectin up-regulation. Proc Natl Acad Sci USA. 108:3725–3730. 2011. View Article : Google Scholar : PubMed/NCBI

13 

Gupta GP and Massague J: Cancer metastasis: Building a framework. Cell. 127:679–695. 2006. View Article : Google Scholar : PubMed/NCBI

14 

Aerts HJ, Velazquez ER, Leijenaar RT, Parmar C, Grossmann P, Carvalho S, Bussink J, Monshouwer R, Haibe-Kains B, Rietveld D, et al: Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun. 5:40062014. View Article : Google Scholar : PubMed/NCBI

15 

Abdullah N, Ngah UK and Aziz SA: Image classification of brain MRI using support vector machine. 2011 IEEE International Conference on Imaging Systems and Techniques. 242–247. 2011. View Article : Google Scholar

16 

Connell JJ, Chatain G, Cornelissen B, Vallis KA, Hamilton A, Seymour L, Anthony DC and Sibson NR: Selective permeabilization of the blood-brain barrier at sites of metastasis. J Natl Cancer Inst. 105:1634–1643. 2013. View Article : Google Scholar : PubMed/NCBI

17 

Holli KK, Harrison L, Dastidar P, Waljas M, Liimatainen S, Luukkaala T, Ohman J, Soimakallio S and Eskola H: Texture analysis of MR images of patients with mild traumatic brain injury. BMC Med Imaging. 10:82010. View Article : Google Scholar : PubMed/NCBI

18 

Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JHM, Beasley MB, Chirieac LR, Dacic S, Duhig E, Flieder DB, et al: The 2015 World Health organization classification of lung tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification. J Thorac Oncol. 10:1243–1260. 2015. View Article : Google Scholar : PubMed/NCBI

19 

Chernov MF, Nakaya K, Izawa M, Hayashi M, Usuba Y, Kato K, Muragaki Y, Iseki H, Hori T and Takakura K: Outcome after radiosurgery for brain metastases in patients with low Karnofsky performance scale (KPS) scores. Int J Radiat Oncol Biol Phys. 67:1492–1498. 2007. View Article : Google Scholar : PubMed/NCBI

20 

Karcioglu O, Topacoglu H and Dikme O and Dikme O: A systematic review of the pain scales in adults: Which to use? Am J Emerg Med. 36:707–714. 2018. View Article : Google Scholar : PubMed/NCBI

21 

Zimny A, Szmyrka-Kaczmarek M, Szewczyk P, Bladowska J, Pokryszko-Dragan A, Gruszka E, Wiland P and Sasiadek M: In vivo evaluation of brain damage in the course of systemic lupus erythematosus using magnetic resonance spectroscopy, perfusion-weighted and diffusion-tensor imaging. Lupus. 23:10–19. 2014. View Article : Google Scholar : PubMed/NCBI

22 

Bladowska J, Zimny A, Knysz B, Malyszczak K, Koltowska A, Szewczyk P, Gasiorowski J, Furdal M and Sasiadek MJ: Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: A pilot study. J Hepatol. 59:651–657. 2013. View Article : Google Scholar : PubMed/NCBI

23 

Loizou CP, Petroudi S, Seimenis I, Pantziaris M and Pattichis CS: Quantitative texture analysis of brain white matter lesions derived from T2-weighted MR images in MS patients with clinically isolated syndrome. J Neuroradiol. 42:99–114. 2015. View Article : Google Scholar : PubMed/NCBI

24 

Mayerhoefer ME, Szomolanyi P, Jirak D, Berg A, Materka A, Dirisamer A and Trattnig S: Effects of magnetic resonance image interpolation on the results of texture-based pattern classification: a phantom study. Invest Radiol. 44:405–411. 2009. View Article : Google Scholar : PubMed/NCBI

25 

Becker AS, Schneider MA, Wurnig MC, Wagner M, Clavien PA and Boss A: Radiomics of liver MRI predict metastases in mice. Eur Radiol Exp. 2:112018. View Article : Google Scholar : PubMed/NCBI

26 

Yao J, Dwyer A, Summers RM and Mollura DJ: Computer-aided diagnosis of pulmonary infections using texture analysis and support vector machine classification. Acad Radiol. 18:306–314. 2011. View Article : Google Scholar : PubMed/NCBI

27 

van Griethuysen JJM, Fedorov A, Parmar C, Hosny A, Aucoin N, Narayan V, Beets-Tan RGH, Fillion-Robin JC, Pieper S and Aerts HJWL: Computational radiomics system to decode the radiographic phenotype. Cancer Res. 77:e104–e107. 2017. View Article : Google Scholar : PubMed/NCBI

28 

Nasim F, Sabath BF and Eapen GA: Lung Cancer. Med Clin North Am. 103:463–473. 2019. View Article : Google Scholar : PubMed/NCBI

29 

Kay FU, Kandathil A, Batra K, Saboo SS, Abbara S and Rajiah P: Revisions to the Tumor, Node, Metastasis staging of lung cancer (8th edition): Rationale, radiologic findings and clinical implications. World J Radiol. 9:269–279. 2017. View Article : Google Scholar : PubMed/NCBI

30 

Castellano G, Bonilha L, Li LM and Cendes F: Texture analysis of medical images. Clin Radiol. 59:1061–1069. 2004. View Article : Google Scholar : PubMed/NCBI

31 

Napel S, Mu W, Jardim-Perassi BV, Aerts HJWL and Gillies RJ: Quantitative imaging of cancer in the postgenomic era: Radio(geno)mics, deep learning, and habitats. Cancer. 124:4633–4649. 2018. View Article : Google Scholar : PubMed/NCBI

32 

Gallego-Ortiz C and Martel AL: Using quantitative features extracted from T2-weighted MRI to improve breast MRI computer-aided diagnosis (CAD). PLoS One. 12:e01875012017. View Article : Google Scholar : PubMed/NCBI

33 

Nachimuthu DS and Baladhandapani A: Multidimensional texture characterization: On analysis for brain tumor tissues using MRS and MRI. J Digit Imaging. 27:496–506. 2014. View Article : Google Scholar : PubMed/NCBI

34 

Galm BP, Martinez-Salazar EL, Swearingen B, Torriani M, Klibanski A, Bredella MA and Tritos NA: MRI texture analysis as a predictor of tumor recurrence or progression in patients with clinically non-functioning pituitary adenomas. Eur J Endocrinol. 179:191–198. 2018. View Article : Google Scholar : PubMed/NCBI

35 

Holli-Helenius K, Salminen A, Rinta-Kiikka I, Koskivuo I, Bruck N, Bostrom P and Parkkola R: MRI texture analysis in differentiating luminal A and luminal B breast cancer molecular subtypes-a feasibility study. BMC Med Imaging. 17:692017. View Article : Google Scholar : PubMed/NCBI

36 

Herlidou-Meme S, Constans JM, Carsin B, Olivie D, Eliat PA, Nadal-Desbarats L, Gondry C, Le Rumeur E, Idy-Peretti I and de Certaines JD: MRI texture analysis on texture test objects, normal brain and intracranial tumors. Magn Reson Imaging. 21:989–993. 2003. View Article : Google Scholar : PubMed/NCBI

37 

Kjaer L, Ring P, Thomsen C and Henriksen O: Texture analysis in quantitative MR imaging. Tissue characterisation of normal brain and intracranial tumours at 1.5 T. Acta Radiol. 36:127–135. 1995. View Article : Google Scholar : PubMed/NCBI

38 

Mougiakakou SG, Valavanis IK, Nikita A and Nikita KS: Differential diagnosis of CT focal liver lesions using texture features, feature selection and ensemble driven classifiers. Artif Intell Med. 41:25–37. 2007. View Article : Google Scholar : PubMed/NCBI

39 

Lerski RA, Straughan K, Schad LR, Boyce D, Bluml S and Zuna I: MR image texture analysis-an approach to tissue characterization. Magn Reson Imaging. 11:873–887. 1993. View Article : Google Scholar : PubMed/NCBI

40 

Cristofori I, Zhong W, Chau A, Solomon J, Krueger F and Grafman J: White and gray matter contributions to executive function recovery after traumatic brain injury. Neurology. 84:1394–1401. 2015. View Article : Google Scholar : PubMed/NCBI

41 

Barbey AK, Colom R, Solomon J, Krueger F, Forbes C and Grafman J: An integrative architecture for general intelligence and executive function revealed by lesion mapping. Brain. 135:1154–1164. 2012. View Article : Google Scholar : PubMed/NCBI

42 

Woodard GA, Jones KD and Jablons DM: Lung cancer staging and prognosis. Cancer Treat Res. 170:47–75. 2016. View Article : Google Scholar : PubMed/NCBI

43 

Derks JL, Leblay N, Thunnissen E, van Suylen RJ, den Bakker M, Groen HJM, Smit EF, Damhuis R, van den Broek EC, Charbrier A, et al: Molecular subtypes of pulmonary large-cell neuroendocrine carcinoma predict chemotherapy treatment outcome. Clin Cancer Res. 24:33–42. 2018. View Article : Google Scholar : PubMed/NCBI

44 

Schwartz AM and Rezaei MK: Diagnostic surgical pathology in lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 143 (5 Suppl):e251S–e262S. 2013. View Article : Google Scholar : PubMed/NCBI

45 

Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, Beer DG, Powell CA, Riely GJ, Van Schil PE, et al: International association for the study of lung cancer/american thoracic society/european respiratory society: International multidisciplinary classification of lung adenocarcinoma: Executive summary. Proc Am Thorac Soc. 6:244–285. 2011.

46 

Travis WD, Brambilla E and Riely GJ: New pathologic classification of lung cancer: Relevance for clinical practice and clinical trials. J Clin Oncol. 31:992–1001. 2013. View Article : Google Scholar : PubMed/NCBI

47 

Blandin Knight S, Crosbie PA, Balata H, Chudziak J, Hussell T and Dive C: Progress and prospects of early detection in lung cancer. Open Biol. 7(pii): 1700702017. View Article : Google Scholar : PubMed/NCBI

48 

Walters S, Maringe C, Coleman MP, Peake MD, Butler J, Young N, Bergstrom S, Hanna L, Jakobsen E, Kolbeck K, et al: Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: A population-based study, 2004–2007. Thorax. 68:551–564. 2013. View Article : Google Scholar : PubMed/NCBI

49 

Dennie C, Thornhill R, Sethi-Virmani V, Souza CA, Bayanati H, Gupta A and Maziak D: Role of quantitative computed tomography texture analysis in the differentiation of primary lung cancer and granulomatous nodules. Quant Imaging Med Surg. 6:6–15. 2016.PubMed/NCBI

50 

Wibmer A, Hricak H, Gondo T, Matsumoto K, Veeraraghavan H, Fehr D, Zheng J, Goldman D, Moskowitz C, Fine SW, et al: Haralick texture analysis of prostate MRI: Utility for differentiating non-cancerous prostate from prostate cancer and differentiating prostate cancers with different Gleason scores. Eur Radiol. 25:2840–2850. 2015. View Article : Google Scholar : PubMed/NCBI

51 

MacKay JW, Murray PJ, Low SB, Kasmai B, Johnson G, Donell ST and Toms AP: Quantitative analysis of tibial subchondral bone: Texture analysis outperforms conventional trabecular microarchitecture analysis. J Magn Reson Imaging. 43:1159–1170. 2016. View Article : Google Scholar : PubMed/NCBI

52 

Mayerhoefer ME, Szomolanyi P, Jirak D, Materka A and Trattnig S: Effects of MRI acquisition parameter variations and protocol heterogeneity on the results of texture analysis and pattern discrimination: An application-oriented study. Med Phys. 36:1236–1243. 2009. View Article : Google Scholar : PubMed/NCBI

53 

Collewet G, Strzelecki M and Mariette F: Influence of MRI acquisition protocols and image intensity normalization methods on texture classification. Magn Reson Imaging. 22:81–91. 2004. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

April-2020
Volume 19 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Xu J, Cui X, Wang B, Wang G, Han M, Li R, Qi Y, Xiu J, Yang Q, Liu Z, Liu Z, et al: Texture analysis of early cerebral tissue damage in magnetic resonance imaging of patients with lung cancer. Oncol Lett 19: 3089-3100, 2020
APA
Xu, J., Cui, X., Wang, B., Wang, G., Han, M., Li, R. ... Han, M. (2020). Texture analysis of early cerebral tissue damage in magnetic resonance imaging of patients with lung cancer. Oncology Letters, 19, 3089-3100. https://doi.org/10.3892/ol.2020.11426
MLA
Xu, J., Cui, X., Wang, B., Wang, G., Han, M., Li, R., Qi, Y., Xiu, J., Yang, Q., Liu, Z., Han, M."Texture analysis of early cerebral tissue damage in magnetic resonance imaging of patients with lung cancer". Oncology Letters 19.4 (2020): 3089-3100.
Chicago
Xu, J., Cui, X., Wang, B., Wang, G., Han, M., Li, R., Qi, Y., Xiu, J., Yang, Q., Liu, Z., Han, M."Texture analysis of early cerebral tissue damage in magnetic resonance imaging of patients with lung cancer". Oncology Letters 19, no. 4 (2020): 3089-3100. https://doi.org/10.3892/ol.2020.11426